SRXH Tumbles 15% After-Earnings — Acquisition Sparks Doubt, Not Optimism

Why is SRXH stock dropping today?

SRx Health (NYSE: SRXH) stock plunged more than 15% in post-market trading after releasing its Q1 FY2026 earnings. The stock closed at $0.1485 on the session before and dropped to $0.1258 in after-hours trading. This sharp drop came on the heels of a key catalyst: the company announced results showing a net revenue of $2.8 million with a 38% gross margin, but also reported a net loss of $8.6 million for the quarter.

Even more, the company revealed it has entered into a final agreement to acquire EMJX, a digital asset management company. While the move signals a strategic pivot toward digital assets, the market appears to have reacted with skepticism.

Still, the move wasn’t entirely a surprise. The stock had already been in a downward trend, with MA20 and MA50 both trending south. A 15% overnight drop in a post-market setting is a strong signal that investors are either re-evaluating the company’s fundamentals or are reacting to the acquisition news with caution.

The bottom line? SRx Health’s earnings and strategic move triggered an immediate sell-off, and market sentiment turned quickly against the stock.

What technical levels should investors watch for SRXH?

The stock is currently trading near the lower end of its 60-day range, with support and resistance levels coming into focus. The nearest support is at $0.0786, while the nearest resistance is at $0.1485, the previous day's close. The stock has historically traded between $0.0786 and $0.7102, placing it firmly in the lower range as of this writing.

Still, the 20-day moving average (MA20) stands at $0.1497, and the 50-day MA is at $0.2447. These levels suggest the stock has a long way to go to regain bullish momentum.

Crucially, the RSI is at 48.28, which is neutral but does not support a strong reversal signal. The ATR14 is at $0.0263, indicating moderate volatility. That means the stock could swing between these levels without much directional bias.

For now, SRx Health (NYSE: SRXH) support and resistance levels should be closely watched as the stock tries to find a floor or bounce back from this sharp decline.

What to watch next for SRXH stock?

Given the volatility, the near-term path for SRXH hinges on two key factors: volume and price behavior around key levels. Volume on the day was significantly higher than the 60-day average, signaling some participation but not overwhelming conviction. The relative volume is 1.095x, which is a strong confirmation of the price move.

That said, the market is still uncertain. The acquisition is a major strategic shift, and while it could unlock new value in the long term, the near-term risks include regulatory hurdles and shareholder approval delays. These uncertainties may keep short-term volatility high.

Looking ahead, traders and investors should keep a close eye on the $0.08 support and $0.15 resistance. If the stock breaks below $0.08, it could trigger a deeper pullback. Conversely, a rally back above $0.15 could suggest the sell-off is being treated as a buying opportunity by bargain hunters.

At the end of the day, the stock’s next move will depend on whether the market interprets the earnings and acquisition news as a positive pivot or a warning sign. Until more clarity emerges, the path for SRXH remains uncertain but highly watchable.